The U.S. Food and Drug Administration (FDA) will hold a daylong public meeting on March 17 focused exclusively on psoriasis. This fall, the FDA will issue a Voice of the Patient Report encapsulating the viewpoints expressed during the meeting and the comment period following.
We invite health care professionals to turn up the volume on patients’ voices by sending in comments to the public docket.
Part of the agency’s commitments under the fifth authorization of the Prescription Drug User Fee Act (PDUFA V), this meeting is intended to spotlight the patient experience and provide the FDA a better understanding of patient perspectives on disease symptoms and treatments. For individuals unable to attend the meeting, comments are welcome via a public docket for up to two months after the meeting. Because these reports may be referenced in FDA reviews of new therapy applications, the meeting and comment period could have a direct impact on agency actions.
Health care professionals don’t need to wait for the FDA meeting to hear the patient experience firsthand. Every day, doctors, nurses and other providers help patients overcome the challenges of living with psoriatic disease. Maybe you were the provider who finally found a patient the right treatment after trying and failing several others. Maybe you were the only one that patient opened up to regarding genital psoriasis or other tough-to-treat locations.
We hope that patients at the meeting share these experiences. But we’re counting on health care professionals to make sure that no patient experiences get left out. That includes patients from underrepresented populations, such as pediatric patients, patients of color and patients with rare forms of psoriasis.
How does psoriasis impact your patients’ relationships? Are they happy with their treatment options? Have side effects—or the fear of side effects—gotten in the way of treatment? These are just some of the topics the FDA would like to hear about. Click here to see the full list. Scroll down to the middle of the page and look for “Topic 1” and “Topic 2.”
Think about some of the experiences your patients have shared with you and consider passing them along to the FDA via this link. Simply click “comment now” to share what you’ve heard from patients on the questions which will be discussed on March 17th.
Driving discovery, creating community
For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.